Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis.
We describe a case of relapsed intravascular lymphomatosis (IVL) successfully treated with autologous PBSCT. A 59-year-old Japanese female patient with IVL who had achieved CR after six courses of biweekly CHOP therapy developed lymphoma. She achieved a second CR after six courses of modified biweekly CHOP therapy, followed by autologous PBSCH and high-dose chemotherapy (CBDCA, VP-16, MCNU, CY) with PBSCT. There has not been any evidence of recurrence 48 months after PBSCT. Our case suggests that PBSC is acceptable as a source for stem cell rescue in IVL.
Yamaguchi
M
M
Second Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan.
Kimura
M
M
Watanabe
Y
Y
Taniguchi
M
M
Masuya
M
M
Kageyama
S
S
Katayama
N
N
Ohno
T
T
Kita
K
K
Shiku
H
H
D018952:Antigens, CD34; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018572:Disease-Free Survival; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006412:Hematopoietic Stem Cells; D006801:Humans; D008223:Lymphoma / Q000209:etiology / Q000628:therapy*; D008875:Middle Aged; D012008:Recurrence; D014182:Transplantation, Autologous; D019043:Vascular Neoplasms / Q000209:etiology / Q000628:therapy*
D018952:Antigens, CD34